Abiopharma

(90% Positive) IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Announces Clinical Development Update

New SEC Form for ResMed Inc.

Director FARRELL PETER C 🔴 sold 2.0K shares of RESMED INC (RMD) at $248.83 Transaction Date: Jan 07, 2026 | Filing ID: 000004

(90% Positive) Prelude Therapeutics Incorporated (PRLD) Provides Update on jurisdiction for which such offer

(56% Neutral) Perspective Therapeutics, Inc. (CATX) Announces Enrollment Update for treatments Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(10% Negative) Aquestive Therapeutics, Inc. (AQST) Announces Regulatory Update

(10% Negative) Immunocore Holdings plc (IMCR) Announces Delay in outcomes Development Timeline Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(98% Neutral) uniQure N.V. (QURE) Provides Update on pathway for AMT-130

uniQure Announces Type A Meeting Scheduled with FDA

Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference

(99% Neutral) BioCryst Pharmaceuticals, Inc. (BCRX) Announces Regulatory Update

iBio Announces $26 Million Private Placement

Bruker - Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI

Schrödinger, Inc. - Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign